The London-listed biopharmaceutical company, the Bahamian fund and the, er, potential row...
Thursday, 6 May 2021, 12:54 pm
Hemogenyx Pharmaceuticals was once the the darling of the small cap market but now the shares are languishing at a five-year low, causing consternation among the company's backers.
Some are blaming today's dire state of the shares on Mint Capital, a little known investment house based in the Bahamas...